These findings suggest that the tropism-mediated cancer specificity of V937 was sufficient to ensure safe locoregional and systemic delivery of the virus to patients, despite normal tissues also expressing its entry molecules ICAM-1 and DAF. This evidence concerns the gene ICAM1 and cancer.